Skip to content ↓

Construction Update

Vassar streetscape

Trees removed as part of the new security and landscape enhancement project near buildings 39, 13, 31 and 24 will be replaced with new trees as well as added landscaping, irrigation, teak benches, new lighting and sidewalks. Traffic in and out of the entrance to Building 39 will experience delays or lane shifts as work on the new entrance from Vassar Street continues. Pedestrian traffic has been moved next to Building 38 to allow for construction of new sidewalks near Vassar Street. Traffic will continue to flow one-way westbound along the southern side of the street between Main Street and Massachusetts Avenue. All major crosswalks and driveways are accessible.

MDC Memorial Drive rehabilitation project

Work continues on the Ames Street and Wadsworth Street U-turns. Construction on the underpass at Massachusetts Avenue and Memorial Drive will begin later this month. The underpass will be closed to traffic from Friday evening, April 18 through the next day. Traffic will be detoured to the surface and ramps.

Baker House

Installation of new windows and restoration of stucco and brick has begun. Some construction will take place in April. Site preparation will take place later this spring; work will continue through August.

NECCO conversion

DSF Cambridge purchased and is rehabilitating the former NECCO factory building on Massachusetts Avenue for use as biotechnology laboratory space. Novartis will be occupying the entire building. All NECCO equipment has been removed, most rooftop equipment has been installed, windows are being replaced and the construction of a parking garage has begun. The entire project is scheduled to be completed in April 2004.

A version of this article appeared in MIT Tech Talk on April 16, 2003.

Related Topics

More MIT News

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story